CPE and Alzheimer disease: In addition, the LC3II/LC3I ratio was decreased in the 3 × Tg-AD mice compared to the non-Tg mice, and increased with AAV-NF-α1/CPE or AAV-NF-α1/CPE-E342Q treatment (Fig. 7c).